adverse effects of glp-1 receptor agonists Frontiers Frontiers | Exploring the multifaceted
Description
Background: The evidence on berberine stimulating the secretion of GLP-1 in intestinal L cell has been studied
Arizona OPEN ACCESS PUBLISHED:30 October 2024 CITATION:Chakkera, S
The clinical data is real
Learn about their benefits and side effects.
Purpose Chronic kidney disease (CKD) is one of the most common complications of type 2 diabetes (T2D), and CKD-related disability and mortality are increasing despite the recent advances in diabetes management
For external use only
